// App-Quantinova.ai

4827 : Dasatinib Restores Full Donor Chimerism in Animatinib - Resistant Ph+ ALL Childwith E255K Gene Mutation Relapse Dafter Allo HSCT

Researchers

Presenter

  • Gevorg Tamamyan

Principal Investigators

  • Kang-Hsi Wu

Medical Centers

  • Hematology, Yerevan State Medical University, Muratsan Hospital Complex. Clinic of Chemotherapy, Yerevan, Armenia, TAICHUNG, Taiwan

  • Pediatric Hem./Onc., Children's Hospital, China Medical University and Hospital, Taichung, Taiwan

  • Children's Hospital, Taichung, Taiwan

Locations

  • Taiwan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • dasatinib

  • Imatinib

  • IkT001

  • L-Tyrosine

  • Allopurinol

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved